Free Trial

IceCure Medical (ICCM) Competitors

IceCure Medical logo
$1.00 +0.12 (+13.28%)
As of 03:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ICCM vs. INGN, INFU, KRMD, MGRM, CVRX, CV, TLSI, ELMD, BSGM, and LNSR

Should you be buying IceCure Medical stock or one of its competitors? The main competitors of IceCure Medical include Inogen (INGN), InfuSystem (INFU), KORU Medical Systems (KRMD), Monogram Orthopaedics (MGRM), CVRx (CVRX), CapsoVision (CV), TriSalus Life Sciences (TLSI), Electromed (ELMD), Biosig Technologies (BSGM), and LENSAR (LNSR). These companies are all part of the "medical equipment" industry.

IceCure Medical vs. Its Competitors

IceCure Medical (NASDAQ:ICCM) and Inogen (NASDAQ:INGN) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends.

0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 89.9% of Inogen shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Comparatively, 1.5% of Inogen shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

IceCure Medical has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IceCure Medical$3.29M17.84-$15.32M-$0.16-6.25
Inogen$335.70M0.62-$35.89M-$1.06-7.22

Inogen has a net margin of -7.58% compared to IceCure Medical's net margin of -317.62%. Inogen's return on equity of -13.77% beat IceCure Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
IceCure Medical-317.62% -136.96% -71.46%
Inogen -7.58%-13.77%-8.52%

IceCure Medical has a beta of 0.32, indicating that its share price is 68% less volatile than the S&P 500. Comparatively, Inogen has a beta of 1.72, indicating that its share price is 72% more volatile than the S&P 500.

In the previous week, IceCure Medical had 4 more articles in the media than Inogen. MarketBeat recorded 4 mentions for IceCure Medical and 0 mentions for Inogen. Inogen's average media sentiment score of 0.50 beat IceCure Medical's score of -0.01 indicating that Inogen is being referred to more favorably in the news media.

Company Overall Sentiment
IceCure Medical Neutral
Inogen Positive

IceCure Medical currently has a consensus price target of $2.39, suggesting a potential upside of 138.50%. Inogen has a consensus price target of $11.00, suggesting a potential upside of 43.70%. Given IceCure Medical's stronger consensus rating and higher possible upside, research analysts clearly believe IceCure Medical is more favorable than Inogen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IceCure Medical
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.00
Inogen
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

IceCure Medical beats Inogen on 10 of the 17 factors compared between the two stocks.

Get IceCure Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICCM vs. The Competition

MetricIceCure MedicalMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$58.70M$7.70B$5.76B$9.75B
Dividend YieldN/A2.69%4.40%4.10%
P/E Ratio-6.2574.8230.8325.91
Price / Sales17.8449.39469.77121.46
Price / CashN/A25.5525.7828.79
Price / Book8.337.729.466.03
Net Income-$15.32M$242.04M$3.27B$265.29M
7 Day Performance12.07%-0.86%2.37%2.86%
1 Month Performance-6.54%-0.57%3.88%1.23%
1 Year Performance39.39%8.25%30.52%19.11%

IceCure Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICCM
IceCure Medical
1.8744 of 5 stars
$1.00
+13.3%
$2.39
+138.5%
+23.1%$58.70M$3.29M-6.2560Gap Up
High Trading Volume
INGN
Inogen
4.199 of 5 stars
$7.55
+1.2%
$11.00
+45.7%
-38.0%$201.72M$335.70M-7.121,030Positive News
INFU
InfuSystem
3.505 of 5 stars
$9.53
-1.0%
$12.50
+31.2%
N/A$194.66M$139.89M158.86410
KRMD
KORU Medical Systems
1.0375 of 5 stars
$4.21
+1.0%
$4.63
+9.9%
+86.4%$192.80M$33.65M-46.7880Positive News
MGRM
Monogram Orthopaedics
1.7766 of 5 stars
$5.32
-0.2%
$5.40
+1.5%
+58.4%$190.22M$370K-10.6428News Coverage
Analyst Revision
CVRX
CVRx
2.5373 of 5 stars
$6.87
-2.3%
$14.00
+103.8%
-10.7%$183.85M$51.29M-3.27160Positive News
CV
CapsoVision
N/A$4.00
+3.9%
$5.50
+37.5%
N/A$178.43MN/A0.0090
TLSI
TriSalus Life Sciences
3.0655 of 5 stars
$4.86
+6.8%
$10.75
+121.2%
-10.1%$172.17M$29.43M-4.12106
ELMD
Electromed
2.0671 of 5 stars
$19.69
+4.0%
$33.50
+70.1%
+27.5%$165.12M$61.44M26.25160News Coverage
Positive News
BSGM
Biosig Technologies
2.0423 of 5 stars
$5.48
+10.3%
$10.00
+82.5%
+1,104.7%$156.15M$40K0.0050High Trading Volume
LNSR
LENSAR
0.6984 of 5 stars
$12.75
+0.8%
$15.00
+17.6%
+173.3%$150.98M$53.49M-3.03110News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:ICCM) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners